Skip to main content

Advertisement

Log in

Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis

  • Originals
  • Published:
Neuroradiology Aims and scope Submit manuscript

Summary

Magnetic resonance scans of 74 patients with multiple sclerosis participating in a controlled trial were compared 6 months before and at the end of a 24–32 months-treatment period with either Cyclosporin A (n=31) or Azathioprine (n=43). Both qualitative rating and computation of lesion volume showed deterioration in more than 40% of the patients, while by clinical criteria only 10–30% were worse. No significant difference was noted when the two treatment groups were compared. If careful repositioning and standardized image parameters are used, MRI is an indispensable tool for the objective determination of disease progression in MS although it cannot replace clinical examination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Young IR, Hall AS, Pallis CA, Legg NJ, Bydder GM, Steiner RE (1981) Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet II: 1063–1066

    Google Scholar 

  2. Poser CM, Paty DW, Scheinberg L, Mc Donald WI, Davis FA, Ebers GS, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227–231

    Google Scholar 

  3. Asbury A, Herndon R, McFarland H, Mc Donald WI, Mc Illroy WJ, Paty DW, Prineas JW, Scheinberg LC, Wolinsky JS (1986) Use of Magnetic Resonance Imaging in the diagnosis of multiple sclerosis. Magn Reson Med 3: 821–822

    Google Scholar 

  4. Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, Mc Dowell F, Nagler B, Sibley W, Tourtellotte W, Willmon TL (1965) Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 122: 552–568

    Google Scholar 

  5. Kappos L, Patzold U, Dommasch D, Poser S, Haas J, Krauseneck P, Malin J-P, Fierz W, Graffenried v. B, Gugerli US (1987) Cyclosporine versus Azathioprine in the long-term treatment of multiple sclerosis-results of the German multicenter study. Ann Neurol (in press)

  6. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444–1452

    Google Scholar 

  7. Stewart WA, Hall LD, Berry K, Paty DW (1984) Correlation between NMR scan and brain slice data in multiple sclerosis. Lancet 1: 412

    Google Scholar 

  8. Bewermeyer H, Huber M, Ebhardt G (1987) Korrelation neuroradiologischer und pathologisch-anatomischer Befunde bei einem Fall von multipler Sklerose. Med Klin 82: 255–257

    Google Scholar 

  9. Johnson MA, Li DK, Bryant DF, Payne JA (1984) Magnetic resonance imaging: serial observations in multiple sclerosis. AJNR 5: 495–499

    Google Scholar 

  10. Costantino A, Black SE, Carr T, Nicholson RL, Noseworthy JH (1986) Dorsal midbrain syndrome in multiple sclerosis with magnetic resonance imaging correlation. Can J Neurol Sci 13: 62–65

    Google Scholar 

  11. Baum K, Girke W, Braeu H, Weiss T, Mitsch E, Felix R (1985) Zur Bedeutung der Magnetischen Resonanz-Tomographie bei Encephalomyelitis disseminata. Nervenarzt 56: 666–672

    Google Scholar 

  12. Paty DW, Palmer M, Bergstrom M, Grochowski E, Apted C, Li D, Hashimoto S (1986) MRI in MS: Quantitative changes in the size of lesions over 6 months in the placebo limb of a therapeutic trial (Abstract). Can J Neurol Sci 13: 168

    Google Scholar 

  13. Grossman RI, Gonzalez-Scarano F, Atlas SW, Galetta S, Silberberg DH (1986) Multiple Sclerosis: Gadolinium enhancement in MR imaging. Radiology 161: 721–725

    Google Scholar 

  14. Kappos L, Städt D, Keil W (1987) Magnetische Resonanztomographie mit Gadolinium-eine Möglichkeit zur Erkennung aktiver Plaques bei Multipler Sklerose. Psycho 13: 386–389

    Google Scholar 

  15. Borgel F, Hommel M, Pollak P, Gaio JM, Crouzet G, Lebas JF, Pellat J, Perret J (1986) L'imagerie par résonance magneétique dans la slérose en plaques. Rev Neurol (Paris) 142: 598–606

    Google Scholar 

  16. Edwards MK, Farlow MR, Stevens JC (1986) Multiple sclerosis: MRI and clinical correlation. AJR 147: 571–574

    Google Scholar 

  17. Kirshner HS, Tsai SI, Runge VM, Price AC (1985) Magnetic resonance imaging and other techniques in the diagnosis of multiple sclerosis. Arch Neurol 42: 859–863

    Google Scholar 

  18. Matias-Guiu J, Sanz M, Gili J, Molins A, Bonaventura I, Capdevila A (1986) Correlation of MRI with the clinical status of patients with multiple sclerosis (letter). Neurology 36: 1626

    Google Scholar 

  19. Reese L, Carr TJ, Nicholson RL, Lepp EK (1986) Magnetic resonance imaging for detecting lesions of multiple sclerosis: comparison with computed tomography and clinical assessment. Can Med Assoc J 135: 639–643

    Google Scholar 

  20. Stevens JC, Farlow MR, Edwards MK, Yu PI (1986) Magnetic resonance imaging. Clinical correlation in 64 patients with multiple sclerosis. Arch Neurol 43: 1145–1148

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kappos, L., Städt, D., Ratzka, M. et al. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis. Neuroradiology 30, 299–302 (1988). https://doi.org/10.1007/BF00328179

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00328179

Key words

Navigation